Blarcamesine potential novel oral treatment to target upstream Alzheimer’s disease pathology through autophagy enhancementImpairment of autophagy ...

While the Alzheimer’s market is projected to experience strong growth throughout the forecast period across the 8MM, unmet ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

A predictive tool for determining the age at which individuals may develop mild cognitive impairment (MCI) or Alzheimer's ...

Alzheimer’s damages cells that produce acetylcholine, which reduces the amount of this chemical (a neurotransmitter) available to carry messages to other ... Today is strictly a news and information ...

There are many experimental treatments targetting these protein plaques that are being developed and investigated as potential therapies for Alzheimer’s disease. More information about these is ...

The search for effective Alzheimer’s treatments is emerging as a promising market, capturing the attention of major ...

The finding has implications for all of us, write Harvard physician-researchers Christopher Worsham and Anupam Jena.

Recent studies implicate the immune system and a herpes virus as potential contributors to development of disease ...

New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according ...